Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 1:01 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 15,031 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Vascular Clear all

Conditions: Stroke, Hypertension
Interventions: Primary Care Physician Management of blood pressure, Withings Smart Blood Pressure Monitor; Other · Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hypertension
Interventions: grape seed extract, grape seed extract placebo; Dietary Supplement
Lead sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology; Industry
Eligibility: 25 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Refractory Multiple Myeloma
Interventions: Noscapine HCl; Drug
Lead sponsor: Cougar Biotechnology, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 4
States / cities: Los Angeles, California • New York, New York

Conditions: Intracranial Aneurysms, Aneurysm, Brain Aneurysm
Interventions: Balloon Assisted Coiling using MicroVention second-generation hydrogel coils and MicroVention Scepter Occlusion Balloon Catheter.; Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Multiple Myeloma
Interventions: Atiprimod; Drug
Lead sponsor: Callisto Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hypertension
Interventions: High Intensity Intervention, Low Intensity Intervention, All- 6 month pharmacist intervention; Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 249 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Hypertension
Interventions: Telmisartan & Hydrochlorothiazide, Losartan & Hydrochlorothiazide, ABPM; Drug · Procedure
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 805 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 69
States / cities: Huntsville, Alabama • Little Rock, Arkansas • Carmichael, California + 57 more

Conditions: Stroke, Hemiplegia
Interventions: Theraband with exercise video, usual care with advice to exercise; Device · Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: San Diego, California

Conditions: Hypotension, Shock
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: ST Segment Elevation Myocardial Infarction
Interventions: NBS10, placebo; Biological · Other
Lead sponsor: Lisata Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 58
States / cities: Birmingham, Alabama • Huntsville, Alabama • Gilbert, Arizona + 50 more

Conditions: Diabetic Retinopathy
Interventions: Photography of the retina, Retinal photography; Procedure
Lead sponsor: Digital Diagnostics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 7
States / cities: Mesa, Arizona • Phoenix, Arizona • Cedar Rapids, Iowa + 2 more

Conditions: Cardiovascular Diseases, Hypertension, Diet, Healthy
Interventions: Typical American Diet, Plant-Based Diet; Other
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 18 Years to 40 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Arlington, Texas

Conditions: Stroke, Stroke Sequelae, Depression, Cognitive Impairment
Interventions: Mindfulness Based Stress Reduction (MBSR), Stroke Support Group (SSG); Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Acute Coronary Syndrome, Chest Pain
Interventions: HEART Pathway; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 21 Years and older
Enrollment: 282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Coronary Artery Disease
Interventions: Clopidogrel, Placebo; Drug
Lead sponsor: Deutsches Herzzentrum Muenchen; Other
Eligibility: 18 Years and older
Enrollment: 4,005 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Aphasia, Stroke
Interventions: Anodal transcranial direct current stimulation, Sham transcranial direct current stimulation, Speech-language therapy; Device · Behavioral
Lead sponsor: Louisiana State University and A&M College; Other
Eligibility: 18 Years to 85 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Multiple Myeloma
Interventions: Denileukin Diftitox (Ontak); Drug
Lead sponsor: Barbara Ann Karmanos Cancer Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Giant Cell Arteritis, Temporal Arteritis, Horton's Disease
Interventions: Ustekinumab, Prednisone; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 50 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Atherosclerosis
Interventions: Placebo, TriLipix; Drug
Lead sponsor: Piedmont Healthcare; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Retinal Vasculitis
Interventions: aflibercept 2mg; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 290,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Tarrytown, New York

Conditions: Relapsed and Refractory Multiple Myeloma (RRMM)
Interventions: Non-Interventional; Other
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Tarrytown, New York

Conditions: Kidney Transplant Recipients
Interventions: Multivitamin, Placebo; Dietary Supplement
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Healthy
Interventions: Antioxidant, Placebo; Dietary Supplement · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 93 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Twin to Twin Transfusion as Antepartum Condition, Monochorionic Diamniotic Placenta
Interventions: Fetoscopic laser ablation; Procedure
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: Female only
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2031
U.S. locations: 2
States / cities: Seattle, Washington

Search by objective public record fields.

Feasibility of Home Telehealth Monitoring for Improvement in Management of Hypertension for Secondary Stroke Prevention

The Effect of Grape Seed Extract on Blood Pressure in People With Pre-Hypertension

A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma

Hydrogel Balloon Assisted Intracranial Aneurysm Coiling Registry

Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma

Trial of Low and High Intensity Strategies to Maintain BP Control

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

E-Rehabilitation: Aerobic Resistance Training for Stroke Survivors

Systolic Blood Pressure Measurement in Critically-ill Patients

NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Impact of a Plant-Based Diet on Indices of Cardiovascular Health in African Americans

Mindfulness Based Stress Reduction and Post-Stroke Cognition

Efficacy Evaluation of the HEART Pathway in Emergency Department Patients With Acute Chest Pain

Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting

Clinical Feasibility of Transcranial Direct Current Stimulation [tDCS] With Standard Aphasia Therapy

Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous Transplantation

Ustekinumab for the Treatment of Giant Cell Arteritis

AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis

Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

A Multivitamin Comparison Study in Kidney Transplant Recipients.

Racial and Aging Effects of Acute Antioxidant Supplementation

Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome